Manufacturer: Boehringer Ingelheim
Jardiance contains the active substance empagliflozin. Jardiance is a member of a group of drugs called sodium-glucose cotransporter type 2 (SGLT2) inhibitors. What is Jardiance used for Jardiance is used to treat type 2 diabetes in adult patients (18 years of age or older) who cannot be controlled by diet and exercise alone. Jardiance can be used without other medicines in patients who cannot take metformin (another medicine to treat diabetes). Jardiance can also be used with other medicines for the treatment of diabetes. These can be medications taken by mouth or given by injection, such as insulin.